James S Yoder1, Feliks Kogan1, Garry E Gold2,3,4. 1. Department of Radiology, Stanford University, 1201 Welch Rd, Stanford, CA, 94305, USA. 2. Department of Radiology, Stanford University, 1201 Welch Rd, Stanford, CA, 94305, USA. gold@stanford.edu. 3. Bioengineering, Stanford University, Stanford, CA, USA. gold@stanford.edu. 4. Orthopaedic Surgery, Stanford University, Stanford, CA, USA. gold@stanford.edu.
Abstract
PURPOSE OF REVIEW: This review article attempts to summarize the current state and applications of the hybrid imaging modality of PET-MRI to metabolic bone diseases. The advances of PET and MRI are also discussed for metabolic bone diseases as potentially applied via PET-MRI. RECENT FINDINGS: Etiologies and mechanisms of metabolic bone disease can be complex where molecular changes precede structural changes. Although PET-MRI has yet to be applied directly to metabolic bone disease, possible applications exist since PET, specifically 18F-NaF PET, can quantitatively track changes in bone metabolism and is useful for assessing treatment, while MRI can give detailed information on bone water concentration, porosity, and architecture through novel techniques such as UTE and ZTE MRI. Earlier detection and further understanding of metabolic bone disease via PET and MRI could lead to better treatment and prevention. More research using this modality is needed to further understand how it can be implemented in this realm.
PURPOSE OF REVIEW: This review article attempts to summarize the current state and applications of the hybrid imaging modality of PET-MRI to metabolic bone diseases. The advances of PET and MRI are also discussed for metabolic bone diseases as potentially applied via PET-MRI. RECENT FINDINGS: Etiologies and mechanisms of metabolic bone disease can be complex where molecular changes precede structural changes. Although PET-MRI has yet to be applied directly to metabolic bone disease, possible applications exist since PET, specifically 18F-NaF PET, can quantitatively track changes in bone metabolism and is useful for assessing treatment, while MRI can give detailed information on bone water concentration, porosity, and architecture through novel techniques such as UTE and ZTE MRI. Earlier detection and further understanding of metabolic bone disease via PET and MRI could lead to better treatment and prevention. More research using this modality is needed to further understand how it can be implemented in this realm.
Authors: Stacey A Wainwright; Lynn M Marshall; Kristine E Ensrud; Jane A Cauley; Dennis M Black; Teresa A Hillier; Marc C Hochberg; Molly T Vogt; Eric S Orwoll Journal: J Clin Endocrinol Metab Date: 2005-02-22 Impact factor: 5.958
Authors: Yohann Bala; Roger Zebaze; Ali Ghasem-Zadeh; Elizabeth J Atkinson; Sandra Iuliano; James M Peterson; Shreyasee Amin; Åshild Bjørnerem; L Joseph Melton; Helena Johansson; John A Kanis; Sundeep Khosla; Ego Seeman Journal: J Bone Miner Res Date: 2014-06 Impact factor: 6.741
Authors: Janina M Patsch; Xiaojuan Li; Thomas Baum; Samuel P Yap; Dimitrios C Karampinos; Ann V Schwartz; Thomas M Link Journal: J Bone Miner Res Date: 2013-08 Impact factor: 6.741
Authors: Justin J Tse; Ainsley C J Smith; Michael T Kuczynski; Daphne A Kaketsis; Sarah L Manske Journal: Curr Osteoporos Rep Date: 2021-07-22 Impact factor: 5.096